State Street’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19M Buy
747,703
+76,591
+11% +$1.6M ﹤0.01% 2387
2026
Q1
$13.4M Buy
671,112
+234,965
+54% +$5.54M ﹤0.01% 2452
2025
Q4
$11.6M Buy
436,147
+160,022
+58% +$4.12M ﹤0.01% 2574
2025
Q3
$6.56M Buy
276,125
+142,691
+107% +$2.55M ﹤0.01% 2873
2025
Q2
$2.21M Buy
+133,434
New +$2.91M ﹤0.01% 3276

Other funds holding KMTS

State Street's KMTS Position: Q2 2026 in Review

State Street increased its Kestra Medical Technologies (KMTS) stake by 11% in Q2 2026, buying an estimated $1.6M and bringing the position to 747,703 shares worth $19M. The position accounts for ﹤0.01% of the portfolio, ranked #2387.

State Street first reported a position in KMTS in Q2 2025 and has held it in 5 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • State Street held 747,703 shares of Kestra Medical Technologies worth $19M as of Q2 2026.
  • State Street bought 76,591 Kestra Medical Technologies shares in Q2 2026, an estimated $1.6M.
  • Kestra Medical Technologies made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2387 holding.
  • State Street first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 5 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.